Clincosm LogoSign in Get a demo

neuroendocrine neoplasm

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

Recruiting
  • Neuroendocrine Neoplasm
  • Beijing, China
    Chinese PLA General Hospital
May 25, 2023

Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)

Recruiting
  • Neuroendocrine Neoplasm
  • Biospecimen Collection
  • +4 more
  • Duarte, California
  • +3 more
Jan 12, 2023

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
  • +1 more
Nov 8, 2022

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Atypical Carcinoid Tumor, Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor Trial in United States (Cabozantinib

Recruiting
  • Atypical Carcinoid Tumor
  • +18 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +425 more
Aug 12, 2022

Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

Recruiting
  • Lung Cancer
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022

Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,

Active, not recruiting
  • Extensive Stage Small Cell Lung Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Neuroendocrine Tumor Trial in Beijing (Sintilimab, IBI310, Surufatinib)

Recruiting
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
  • +1 more
Dec 7, 2021

Neuroendocrine Tumors, Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma Trial in Xiamen, Harbin (Chidamide, Sintilimab)

Recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Xiamen, Fujian, China
  • +1 more
Nov 22, 2021

Models in Neuroendocrine Neoplasm

Recruiting
  • Neuroendocrine Neoplasm
  • Biopsy, open or laparoscopic surgery
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Sep 19, 2021

Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis

Not yet recruiting
  • Neuroendocrine Neoplasm
  • Biopsy/surgical tissue and peripheral blood
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Jun 12, 2021

Neuroendocrine Tumor Trial in Aarhus (Lu-177-DOTA-Octreotide)

Recruiting
  • Neuroendocrine Neoplasm
  • Aarhus, Palle Juul-Jensens Boulevard, Denmark
    Aarhus University Hospital, department of Nuclear medicine and P
Jun 7, 2021

Meningioma, Metastatic Well Differentiated Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston (Computed

Terminated
  • Meningioma
  • +5 more
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 11, 2021

Bone Metastases in neurOendocrine NEoplasms: naTural History,

Unknown status
  • Bone Metastases
  • Neuroendocrine Neoplasm
    • Milan, Italy
      European Institute of Oncology, IEO, IRCCS
    Jan 20, 2021

    Early Treatment Response in NEN (REBORN)

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Somatostatin analog; chemotherapy
    • Rome, Italy
      Andrea M Isidori
    Dec 2, 2020

    Basal Cell Carcinoma, Medulloblastoma, Adenocarcinoma of Esophagogastric Junction Trial in Chang Chun (ZSP1602)

    Recruiting
    • Basal Cell Carcinoma
    • +5 more
    • Chang Chun, Jilin, China
      Jilin Cancer Hospital
    Jul 20, 2020

    Neuroendocrine Tumor Trial in Changsha (18F-AlF-NOTA-octreotide, PET/CT)

    Unknown status
    • Neuroendocrine Neoplasm
    • Changsha, Hunan, China
      Department of PET Center,Xiangya Hospital,Central South Universi
    Apr 17, 2018

    Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,

    Withdrawn
    • Functional Pancreatic Neuroendocrine Tumor
    • +28 more
    • (no location specified)
    Sep 26, 2017